Showing results (171-180 of 199) with videos related to

Sort By:
Pageof 20
Bone|September 14, 2012
Omentin-1, visfatin and adiponectin levels in relation to bone mineral density in Iranian postmenopausal womenMaasumeh Tohidi, Samad Akbarzadeh, Bagher Larijani, et al.
Nuclear Medicine Communications|July 25, 2012
Preoperative ⁹⁹mTc-sestamibi scintigraphy in patients with primary hyperparathyroidism and concomitant nodular goiter: comparison of SPECT-CT, SPECT, and planar imagingBabak Shafiei, Samaneh Hoseinzadeh, Fereidoun Fotouhi, et al.
Menopause (New York, N.Y.)|April 24, 2009
Relationships among serum receptor of nuclear factor-kappaB ligand, osteoprotegerin, high-sensitivity C-reactive protein, and bone mineral density in postmenopausal women: osteoimmunity versus osteoinflammatoryIraj Nabipour, Bagher Larijani, Katayoun Vahdat, et al.
Cytokine|March 9, 2012
The normoglycemic first-degree relatives of patients with type 2 diabetes mellitus have low circulating omentin-1 and adiponectin levelsSamad Akbarzadeh, Iraj Nabipour, Majid Assadi, et al.
Journal of Bone and Mineral Metabolism|June 10, 2015
Chlamydia pneumoniae and Helicobacter pylori IgG seropositivities are not predictors of osteoporosis-associated bone loss: a prospective cohort studyMohammad Reza Kalantarhormozi, Majid Assadi, Katayoun Vahdat, et al.
Quantitative Imaging in Medicine and Surgery|August 2, 2019
Updates on <sup>18</sup>F-FDG-PET/CT as a clinical tool for tuberculosis evaluation and therapeutic monitoringWei-Ye Yu, Pu-Xuan Lu, Majid Assadi, et al.
Endocrinology, Diabetes & Metabolism Case Reports|July 1, 2021
Oncogenic osteomalacia secondary to glomus tumorRishi Raj, Samaneh Hasanzadeh, Mitra Dashtizadeh, et al.
Perfusion|November 17, 2010
Myocardial perfusion imaging using a technetium-99m sestamibi in asymptomatic and low risk for coronary artery disease patients with diagnosed systemic lupus erythematosusNastaran Baharfard, Mohammad Kazem Shiroodi, Freidoon Fotoohi, et al.
Hellenic Journal of Nuclear Medicine|May 21, 2013
A study of the time of hospital discharge of differentiated thyroid cancer patients after receiving iodine-131 for thyroid remnant ablation treatmentZahra Azizmohammadi, Faraj Tabei, Babak Shafiei, et al.
World Journal of Nuclear Medicine|September 5, 2022
Peptide Receptor Radionuclide Therapy Using <sup>177</sup> Lu-DOTATATE in Advanced Neuroendocrine Tumors (NETs) in a Limited-Resource EnvironmentMohammadreza Kalantarhormozi, Samaneh Hassanzadeh, Seyed Javad Rekabpour, et al.
Pageof 20